Loading clinical trials...

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color | Clinical Trials | Clareo Health

RECRUITINGNANCT05213936

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

The purpose of this study is to evaluate hairstyling techniques aimed at increasing efficacy of scalp cooling in the prevention of chemotherapy-induced alopecia, determine scalp cooling effect on pers...

Lead sponsor: Montefiore Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Beth McLellan, MD

CONTACT

(718) 862-8840 bmclella@montefiore.org

Yana Kost, BA

CONTACT

240-383-6896 yana.kost@einsteinmed.org

Related studies

RECRUITINGNA

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

NCT07502976 · Androgenic Alopecia

RECRUITINGPhase 3

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

NCT07029711 · Severe Alopecia Areata

RECRUITINGPhase 3

Androgenic Alopecia TH07 Clinical Trial

NCT07435012 · Androgenic Alopecia

RECRUITINGPhase 3

Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia

NCT07080931 · Androgenetic Alopecia

RECRUITINGPhase 1/2

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

NCT06826196 · Alopecia Areata (AA)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 15, 2025Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment30

Start dateOct 2022

Last updatedJan 15, 2025

Condition

Alopecia

Locations shown

Montefiore Medical Center

The Bronx, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 15, 2025Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Contacts

Sponsors

Related studies

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

Androgenic Alopecia TH07 Clinical Trial

Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

Trial snapshot

Condition

Locations shown

For caregivers